• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Agilent Technologies Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

    3/17/25 4:30:08 PM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Get the next $A alert in real time by email
    8-K
    0001090872false00010908722025-03-132025-03-13

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): March 13, 2025

     

     

    AGILENT TECHNOLOGIES, INC.

    (Exact name of Registrant as Specified in Its Charter)

     

     

    Delaware

    001-15405

    77-0518772

    (State or Other Jurisdiction
    of Incorporation)

    (Commission File Number)

    (IRS Employer
    Identification No.)

     

     

     

     

     

    5301 Stevens Creek Boulevard

     

    Santa Clara, California

     

    95051

    (Address of Principal Executive Offices)

     

    (Zip Code)

     

    Registrant’s Telephone Number, Including Area Code: 800 227-9770

     

     

    (Former Name or Former Address, if Changed Since Last Report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

    ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:


    Title of each class

     

    Trading
    Symbol(s)

     


    Name of each exchange on which registered

    Common Stock, $0.01 par value

     

    A

     

    New York Stock Exchange

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     


    Item 5.07 – Submission of Matters to a Vote of Security Holders

     

    The Annual Meeting of Stockholders of the Company was held on March 13, 2025 (the “Annual Meeting”). A total of 251,572,214 shares of Common Stock, representing approximately 88.18% of the shares outstanding, were represented at the Annual Meeting. The voting results for each item of business presented at the Annual Meeting, as certified by the Company’s independent inspector of elections, are set forth below:

     

    Proposal No. 1 – The election of two (2) directors for a term of three years. The individuals listed below received the affirmative vote of a majority of the votes cast by the shares present in person or represented by proxy and entitled to vote at the Annual Meeting and were each elected to serve a three-year term.

     

    Name

    For

    Against

    Abstain

    Broker Non-Vote

    Otis W. Brawley, M.D.

    207,584,504

    23,731,738

    511,396

    19,744,576

    Mikael Dolsten, M.D., Ph.D.

    212,971,389

    18,358,871

    497,378

    19,744,576

     

    Directors Mala Anand, Koh Boon Hwee, Heidi K. Kunz, Padraig McDonnell, Daniel K. Podolsky, M.D., Sue H. Rataj, George A. Scangos, Ph.D., and Dow R. Wilson continued in office following the Annual Meeting.

     

    Proposal No. 2 – The non-binding advisory vote to approve the compensation of the Company’s named executive officers was approved as set forth below.

     

    For

    Against

    Abstain

    Broker Non-Vote

    206,742,268

    24,745,081

    340,289

    19,744,576

     

    Proposal No. 3 – The proposal to ratify the Audit and Finance Committee’s appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the 2025 fiscal year was approved as set forth below.

    For

    Against

    Abstain

    Broker Non-Vote(1)

    227,498,057

    23,808,906

    265,251

    0

     

    Proposal No. 4 – The proposal to approve amendments to Agilent’s Second Amended and Restated Certificate of Incorporation to remove supermajority voting requirements.

     

    For

    Against

    Abstain

    Broker Non-Vote

    230,634,534

    719,894

    473,210

    19,744,576

     

    Proposal No. 5 – The proposal to vote on a stockholder proposal regarding the election of each director annually.

     

    For

    Against

    Abstain

    Broker Non-Vote

    224,079,551

    5,491,952

    2,256,135

    19,744,576

     

    Item 9.01. – Financial Statements and Exhibits.

     

    (d) Exhibits

     

    Exhibit No.

     

    Description

     

     

     

    3.1

     

    Third Amended & Restated Certificate of Incorporation

    104

     

    Cover Page Interactive Data File (embedded within the Inline XBRL document)

     

     

     

    (1)

    Pursuant to the rules of the New York Stock Exchange, this proposal constituted a routine matter. Therefore, brokers were permitted to vote without receipt of instructions from beneficial owners.

     


    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

     

     

     

    AGILENT TECHNOLOGIES, INC.

     

     

     

     

    Date:

    March 17, 2025

    By:

    /s/ P. Diana Chiu

     

     

    Name:

    P. Diana Chiu

     

     

    Title:

    Vice President, Assistant General Counsel &

    Assistant Secretary

     


    Get the next $A alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $A

    DatePrice TargetRatingAnalyst
    2/10/2025$135.00 → $145.00Underweight → Equal Weight
    Barclays
    8/28/2024$157.00Overweight
    Wells Fargo
    7/10/2024$135.00 → $150.00Neutral → Buy
    Citigroup
    6/27/2024Outperform → Peer Perform
    Wolfe Research
    6/3/2024$135.00Hold
    Jefferies
    4/5/2024$145.00 → $163.00Hold → Buy
    Stifel
    12/13/2023$140.00Outperform
    Wolfe Research
    12/12/2023$130.00 → $133.00Buy → Neutral
    BofA Securities
    More analyst ratings